Silco Pharmaceuticals Limited (DSE:SILCOPHL)
Bangladesh · Delayed Price · Currency is BDT 15.10
+0.90 (6.34%)
At close: Oct 15, 2026
Silco Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 1,567 | 1,536 | 1,754 | 2,533 | 2,741 | 2,709 | |
Market Cap Growth | -1.31% | -12.43% | -30.74% | -7.58% | 1.15% | 16.52% |
Enterprise Value | 1,540 | 1,518 | 1,703 | 2,491 | 2,643 | 2,599 |
Last Close Price | 15.10 | 14.68 | 16.66 | 23.75 | 25.15 | 23.90 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 45.64 | 36.02 | 38.24 | 36.59 | 32.45 | 32.01 |
PS Ratio | 3.84 | 3.56 | 4.28 | 5.45 | 4.90 | 4.51 |
PB Ratio | 0.65 | 0.64 | 0.75 | 1.09 | 1.20 | 1.20 |
P/TBV Ratio | 0.65 | 0.64 | 0.75 | 1.09 | 1.20 | 1.20 |
P/FCF Ratio | 91.06 | 203.70 | 32375.63 | - | 43.53 | - |
P/OCF Ratio | 21.42 | 19.88 | 20.81 | 14.03 | 16.21 | 10.53 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 3.77 | 3.52 | 4.15 | 5.36 | 4.72 | 4.32 |
EV/EBITDA Ratio | 9.57 | 9.07 | 11.52 | 16.19 | 15.35 | 16.88 |
EV/EBIT Ratio | 22.99 | 19.39 | 28.78 | 37.09 | 27.12 | 32.74 |
EV/FCF Ratio | 89.47 | 201.24 | 31423.90 | - | 41.99 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.01 | 0.03 | 0.06 | - | 0.02 | 0.05 |
Debt / FCF Ratio | 0.08 | 0.66 | 176.56 | - | 0.07 | - |
Net Debt / Equity Ratio | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 |
Net Debt / EBITDA Ratio | -0.17 | -0.13 | -0.14 | -0.32 | -0.35 | -0.42 |
Net Debt / FCF Ratio | -1.59 | -2.82 | -385.79 | 33.89 | -0.96 | 0.54 |
Asset Turnover | 0.14 | 0.16 | 0.15 | 0.17 | 0.21 | 0.23 |
Inventory Turnover | 0.59 | 0.62 | 0.63 | 0.71 | 0.82 | 0.96 |
Quick Ratio | 2.10 | 2.03 | 1.45 | 1.45 | 1.56 | 1.64 |
Current Ratio | 4.81 | 4.71 | 3.39 | 3.40 | 3.61 | 3.72 |
Return on Equity (ROE) | 1.43% | 1.80% | 1.96% | 3.01% | 3.72% | 3.75% |
Return on Assets (ROA) | 1.48% | 1.75% | 1.32% | 1.53% | 2.25% | 1.85% |
Return on Invested Capital (ROIC) | 1.43% | 1.82% | 1.99% | 2.32% | 3.42% | 3.58% |
Return on Capital Employed (ROCE) | 2.60% | 3.10% | 2.40% | 2.70% | 4.00% | 3.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 2.18% | 2.78% | 2.61% | 2.73% | 3.08% | 3.12% |
FCF Yield | 1.10% | 0.49% | 0.00% | -0.06% | 2.30% | -4.40% |
Dividend Yield | 0.73% | 0.74% | 0.59% | 1.23% | 1.89% | 3.83% |
Payout Ratio | 23.68% | 15.82% | 41.72% | 45.43% | 74.15% | 73.25% |
Total Shareholder Return | 0.41% | 0.74% | 0.59% | 1.23% | 1.89% | 3.83% |